Detection of Functional Hematopoietic Stem Cell Niche Using Real-Time Imaging

Blood ◽  
2008 ◽  
Vol 112 (11) ◽  
pp. 550-550
Author(s):  
Tong Yin ◽  
Yucai Xie ◽  
Winfried Wiegraebe ◽  
Xi He ◽  
Linheng Li

Abstract Hematopoietic stem cell (HSC) niches play an essential role in regulating adult stem cell self-renewal and differentiation. HSC niches have only recently been identified based on genetic models that showed a parallel increase in the numbers of both HSCs and osteoblasts, or by static immunolabeling of putative HSCs and the adjacent locations. However, osteoblasts and vasculature were viewed as separate niches with distinctive roles, their interrelationships and interactions with HSCs in vivo remain largely undefined. To study the dynamic interaction between the HSC and its niche, we developed a method of ex vivo imaging stem cells (EVISC) using two-photon microscopy. This method combined the technology of real-time imaging and the functional feature that Flk2−LSK HSCs can be prospectively isolated with high purity and can home to their niche upon transplantation into irradiated recipient mice. Using EVISC in combination with immunoassaying, we found that transplanted HSCs tended to home to the endosteal region predominantly in the trabecular bone area (TBA) compared to compact bone area (CBA) under irradiated conditions, but were randomly distributed and unstable under non-irradiated conditions. Mechanistically, we found that the ratio of expression level of SDF-1 between TBA and CBA was significantly increased in response to irradiation. By monitoring individual HSC behavior using EVISC ranging from minutes to 16-hours, we found that a small portion of the homed HSCs underwent active division in the irradiated mice, coinciding with their initial expansion as measured by flow assay and immunoassay. Our findings suggest that the endosteal region in the trabecular bone area formed a special zone, which normally maintains HSCs but promotes their expansion in response to irradiation. This zone includes both osteoblastic and vascular components and signals, which both underwent dynamic changes from homeostatic to stressed conditions.

Blood ◽  
2010 ◽  
Vol 116 (26) ◽  
pp. 6123-6132 ◽  
Author(s):  
Richard K. Burt ◽  
Robert M. Craig ◽  
Francesca Milanetti ◽  
Kathleen Quigley ◽  
Paula Gozdziak ◽  
...  

Abstract We evaluated the safety and clinical outcome of autologous nonmyeloablative hematopoietic stem cell transplantation (HSCT) in patients with severe Crohn disease (CD) defined as a Crohn Disease Activity Index (CDAI) greater than 250, and/or Crohn Severity Index greater than 16 despite anti–tumor necrosis factor therapy. Stem cells were mobilized from the peripheral blood using cyclophosphamide (2.0 g/m2) and G-CSF (10 μg/kg/day), enriched ex vivo by CD34+ selection, and reinfused after immune suppressive conditioning with cyclophosphamide (200 mg/kg) and either equine antithymocyte globulin (ATG, 90 mg/kg) or rabbit ATG (6 mg/kg). Eighteen of 24 patients are 5 or more years after transplantation. All patients went into remission with a CDAI less than 150. The percentage of clinical relapse-free survival defined as the percent free of restarting CD medical therapy after transplantation is 91% at 1 year, 63% at 2 years, 57% at 3 years, 39% at 4 years, and 19% at 5 years. The percentage of patients in remission (CDAI < 150), steroid-free, or medication-free at any posttransplantation evaluation interval more than 5 years after transplantation has remained at or greater than 70%, 80%, and 60%, respectively. This trial was registered at www.clinicaltrials.gov as NCT0027853.


2019 ◽  
Vol 13 (01) ◽  
pp. 058-063
Author(s):  
Nike Hendrijantini ◽  
Poedjo Hartono ◽  
Muhammad Dimas Aditya Ari ◽  
Fedik Abdul Rantan

Abstract Objective The aim of this study is to evaluate the feasibility of human umbilical cord mesenchymal stem-cell (hUCMSC) therapy in increasing osteoporotic mandibular bone density in a rat model by determining changes in alkaline phosphatase (ALP), osteocalcin, type 1 collagen, and trabecular bone area after treatment. Materials and Methods This research adopted an experimental posttest-only control group design. Thirty female Wistar rats were randomly divided into six groups, namely, a control group with rats postsham surgery (T1), osteoporotic model postovariectomy rats (T2), postovariectomy rats 4 weeks after gelatin injection (T3), postovariectomy rats 8 weeks after gelatin injection (T4), postovariectomy rats 4 weeks after hUCMSC injection (T5), and postovariectomy rats 8 weeks after hUCMSC injection (T6). The rats were all sacrificed for histological and immunohistochemical examinations of ALP, osteocalcin, type 1 collagen, and trabecular bone area. Results Increased expression of ALP, type 1 collagen, and osteocalcin, as well as increased trabecular bone area, was observed in the treatment groups compared with that in the osteoporotic groups. Conclusion hUCMSCs produce significant osteogenic effects and increase osteoporotic mandibular bone density in the animal model. Increases in bone density are demonstrated by the higher levels of ALP, osteocalcin, and type 1 collagen, as well as increases in the trabecular bone area.


2020 ◽  
Author(s):  
Amina Mohammadalipour ◽  
Miguel F. Diaz ◽  
Sumedha Pareek ◽  
Pamela L. Wenzel

2020 ◽  
Vol 9 (11) ◽  
pp. 3502
Author(s):  
Tereza Dekojová ◽  
Lucie Houdová ◽  
Jiří Fatka ◽  
Pavel Pitule ◽  
Pavel Ostašov ◽  
...  

Killer-immunoglobulin-like receptors (KIRs) are critical natural killer (NK) cell regulators. The expression of KIRs is a dynamic process influenced by many factors. Their ligands—HLA(Human Leukocyte Antigen) class I molecules—are expressed on all nucleated cells that keep NK cells under control. In hematopoietic stem cell transplantation (HSCT), NK cells play an essential role in relapse protection. In the presented pilot study, we characterized the dynamic expression of inhibitory KIRS (iKIRs), which protect cells against untoward lysis, in donors and patients during the first three months after HSCT using flow cytometry. The expression of all iKIRs was highly variable and sometimes correlated with patients’ clinical presentation and therapy regiment. Cyclophosphamide (Cy) in the graft-versus-host disease (GvHD) prevention protocol downregulated KIR2DL1 to just 25% of the original donor value, and the FEAM (Fludarabine + Etoposid + Ara-C + Melphalan) conditioning protocol reduced KIR2DL3. In lymphoid neoplasms, there was a slightly increased KIR2DL3 expression compared to myeloid malignancies. Additionally, we showed that the ex vivo activation of NK cells did not alter the level of iKIRs. Our study shows the influence of pre- and post-transplantation protocols on iKIR expression on the surface of NK cells and the importance of monitoring their cell surface.


Sign in / Sign up

Export Citation Format

Share Document